Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
DOTA-PA1
DOTA-PA1(Pan-SSTRs Targeted Precursor PA Derivative)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-M2-9970 | 50mg | inquiry | ||
|
|
||||
Product description
DOTA-PA1(Pan-SSTRs Targeted Precursor PA Derivative) is a chelator-peptide conjugate derived from a pan-somatostatin analogue (referred to as “PA1”), designed to target multiple somatostatin receptor subtypes (SSTR₁, SSTR₂, SSTR₃, SSTR₅). It incorporates the macrocyclic chelator DOTA to enable radiometal complexation (e.g., ^64Cu, ^68Ga) for PET/SPECT imaging or radionuclide therapy.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| Solubility | N/A |
| Molecular formula | N/A |
| Synonyms | 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-pan-somatostatin receptors probe PA1/DOTA-PA1(Pan-SSTRs Targeted Precursor PA Derivative)/1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) -PA1 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
msds of DOTA-PA1 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
